Please assess the completion status of the following clinical trial:

Trial Title: Optimizing Early Enteral Nutrition in Severe Stroke

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Severe stroke occurred in 7 days.~* GCS ≤12 or NIHSS≥11.~* Any cases of profiles #3 through 5 in Water Swallowing Test or with disorder of consciousness.~* Plan to receive enteral feeding for at least 7 days.~* Informed consent.~Exclusion Criteria:~* Gastrointestinal diseases before stroke, such as gastrointestinal resection, malabsorption,and irritable bowel syndrome.~* Brain death.~* Complicated with the disease which only have life expectancy \< 6 months in over 50% patients.~* After cardiac arrest.~* Received parenteral nutrition support.~* Pregnant woman.~* Concurrent severe hepatic or renal dysfunction。~* Unstable hemodynamics.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Full enteral feeding (Type: ACTIVE_COMPARATOR): The caloric goal of the first day is one-third of caloric requirements, the second day is half of caloric requirements, the third day is 70-100% and sustained for 1 week. Protein requirements are calculated at 1.2 to 1.5 g per kilogram of body weight per day.
- Modified full enteral feeding (Type: EXPERIMENTAL): Consistent with full enteral feeding plan, preventively add metoclopramide or mosapride everyday to improve gastrointestinal (GI) motility.
- Permissive underfeeding (Type: EXPERIMENTAL): The caloric goal of the first day is one-third of caloric requirements, the second day is 40-60% and sustained for 1 week. Protein requirements are calculated at 1.2 to 1.5 g per kilogram of body weight per day.

Based on this trial design, predict the completion outcome and termination type (if applicable).